Kevin Land/LinkedIn
Apr 14, 2026, 09:09
Kevin Land: Near Elimination of Vaso-Occlusive Crises in Sickle Cell Disease
Kevin Land, Interim Laboratory and Medical Director Adult HSC Lab at UPMC Hillman Cancer Center, shared a post on LinkedIn։
“How cool is this clinical impact?
Deep normalization of hemoglobin with near‑elimination of vaso‑occlusive events in most treated patients, achieved by directly reactivating fetal hemoglobin at the γ‑globin promoters.
Compared with standard sickle cell care, often with multiple vaso-occlusive crises a year per patient, this represents a step‑change, from disease mitigation and symptomatic care to functional correction.
Early data suggests durable benefit driven by stable stem‑cell editing.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 15:43Webinar on Aplastic Anemia Clinical Case – ASH
-
Apr 14, 2026, 15:42Heghine Khachatryan: Endometriosis Is Not Only a Pain Disorder
-
Apr 14, 2026, 15:36Alisha Tuck: Navigating the First Trimester with Ultrasound and Anticoagulation Management
-
Apr 14, 2026, 15:26Tijjani Balas: The End of ‘Type O Negative’ Shortages? – A New Era in Blood Transfusion
-
Apr 14, 2026, 15:07Carlos Henrique Del Carlo: HFpEF Reimagined as an Adipose Tissue Driven Disease
-
Apr 14, 2026, 15:05Matteo Foschi: ASPERA-R Study Reveals Competing Causes Of Breakthrough Stroke On Anticoagulation
-
Apr 14, 2026, 14:48Samwel Mikaye: From Virchow’s Triad to Prevention of PE in Patients with DVT
-
Apr 14, 2026, 14:43Chokri Ben Lamine: Diamond – Blackfan Anemia and Congenital Dyserythropoietic Anemia Pearls
-
Apr 14, 2026, 14:14From the Clinical Transfusion Working Party – 2025 International Platelet Transfusion Guidelines – ISBT